CompletedPhase 2NCT02402309
A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Studying Sjögren-Larsson syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Aldeyra Therapeutics, Inc.
- Principal Investigator
- William B. Rizzo, MDUniversity of Nebraska
- Intervention
- Active topical NS2 1% dermatologic cream(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2015 – 2016
Study locations (3)
- University of Nebraska Medical Center, Omaha, Nebraska, United States
- Penn State Hershey Medical Center - Department of Dermatology, Hershey, Pennsylvania, United States
- Pediatric and General Dermatology, Fairfax, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02402309 on ClinicalTrials.gov